__timestamp | Johnson & Johnson | Viatris Inc. |
---|---|---|
Wednesday, January 1, 2014 | 21954000000 | 1499100000 |
Thursday, January 1, 2015 | 21203000000 | 1923500000 |
Friday, January 1, 2016 | 19945000000 | 2351400000 |
Sunday, January 1, 2017 | 21420000000 | 2564000000 |
Monday, January 1, 2018 | 22540000000 | 2397300000 |
Tuesday, January 1, 2019 | 22178000000 | 2503400000 |
Wednesday, January 1, 2020 | 22084000000 | 3344600000 |
Friday, January 1, 2021 | 20118000000 | 4529200000 |
Saturday, January 1, 2022 | 19046000000 | 4179100000 |
Sunday, January 1, 2023 | 20112000000 | 4650100000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Johnson & Johnson and Viatris Inc. have showcased contrasting trends in their SG&A expenditures. From 2014 to 2023, Johnson & Johnson's SG&A expenses have seen a modest decline of approximately 13%, reflecting a strategic tightening of operational costs. In contrast, Viatris Inc. has experienced a significant surge, with expenses tripling over the same period. This divergence highlights Johnson & Johnson's focus on cost efficiency, while Viatris Inc. appears to be investing heavily in growth and expansion. As the industry faces increasing pressure to innovate and reduce costs, these trends offer valuable insights into the strategic priorities of these pharmaceutical giants.
Johnson & Johnson and Merck & Co., Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Johnson & Johnson and BioMarin Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: GSK plc vs Viatris Inc.
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Comparing SG&A Expenses: Viatris Inc. vs Pharming Group N.V. Trends and Insights
SG&A Efficiency Analysis: Comparing Viatris Inc. and Ionis Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and MannKind Corporation